- All California State Courts
- U.S. District Court, Northern, Eastern and Central Districts of California
- U.S. Court of Appeals, Ninth Circuit
- Pro hac vice admissions in the numerous states
Rachel Abrams is involved in the firm's product liability and mass tort cases, involving consumer fraud and false advertising of dangerous or defective products.
Areas of Focus
Ms. Abrams actively worked with the Plaintiffs’ Steering Committee (“PSC”) of the Zyprexa Multi-District Litigation (“MDL”), which was conducted in the Eastern District of New York. Ms. Abrams was the Co-Chair of the Science and Expert Committee for the Zyprexa litigation, working extensively with experts in various fields. Furthermore, Ms. Abrams participated in the settlement negotiations on behalf of over 8,000 individual cases that led to an agreement by Eli Lilly and Company to pay $700,000,000 to resolve those individual cases. Ms. Abrams served as a Special Attorney General prosecuting claims by the Attorney General of New Mexico for damages incurred by the State of New Mexico for the inappropriate marketing, promotion and sale of Zyprexa.
Ms. Abrams was appointed by U.S. District Judge Cynthia Rufe to the national Avandia litigation (MDL- 1871) Plaintiffs’ Steering Committee (“PSC”). The PSC consisted of only 12 members nationally.
Ms. Abrams served on the committee for the California State Sulzer Hip Implant litigation and was an active member of the Science and Expert Committee for the DePuy ASR Hip Implant litigation, In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation , MDL No. 2197. She also worked in the CA state coordinated DePuy ASR litigation, DePuy ASR Hip System Cases, JCCP 4649. In addition to being actively involved in the Sulzer-Hip Implant and DePuy ASR litigation, Ms. Abrams has extensive experience in orthopedic device litigation, including litigating cases against Johnson & Johnson/DePuy Orthopaedics, Zimmer, and Stryker Howmedica.
On April 17 2012, Chief U.S. District Justice Joseph R. Goodwin appointed Ms. Abrams to the Plaintiff’s Steering Committee for the coordination of Transvaginal Mesh lawsuits brought by hundreds of women throughout the United States. Specifically, Ms. Abrams was appointed by Judge Goodwin to the PSC of the American Medical Systems, Inc. Pelvic Repair Systems Products Liability Litigation (2:12-md-02325, S.D. WV.), Boston Scientific Corp., Pelvic Repair Systems Product Liability Litigation (2:12-md-02326, S.D. WV.), C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (2:12-md-02187, S.D. WV.), Coloplast Corp. Pelvic Support Systems Product Liability Litigation (2:12-md-02387, S.D. WV.), and Ethicon Inc., Pelvic Repair Systems Products Liability Litigation (2:12-md-02327, S.D. W V.) As a member of the Plaintiff’s Steering Committee, Ms. Abrams had a key leadership role in speaking for injured women and coordinating pretrial proceedings for transvaginal mesh lawsuits.
In 2013, Ms. Abrams was appointed by Judge Cathy Seibel of the U.S. District Court for the Southern District of New York to the PSC of In Re: Mirena IUD Products Liability Litigation (13-MDL-2434).
Further, Ms. Abrams was also appointed by Judge Donovan Frank of the U.S. District Court for the District of Minnesota to the PSC of In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation (13-MDL-2441).
Ms. Abrams was appointed by Judge Matthew Kennelly of the U.S. District Court for the Northern District of Illinois to the PSC of In Re: Testosterone Replacement Therapy Products Liability Litigation (14-MDL-2545).
Ms. Abrams is actively working in both the federal and California state court Talcum Powder litigations (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (16-MDL-2738) and Johnson & Johnson Talcum Powder Cases (JCCP 4872).
Currently, Ms. Abrams serves on the Executive Committee for the California Consolidated cases for Pradaxa (JCCP 4863).
Ms. Abrams was appointed and currently serves as Plaintiffs’ Liaison Counsel In re: Viagra (sildenafil Citrate) and Cialis (Tadalafil) Products Liability Litigation (MDL 2691) by the Honorable Judge Richard Seeborg.
Ms. Abrams has spoken at several seminars and conferences and often lectures in the areas of pharmaceutical/medical device litigation and in particular MDL procedures and litigation. She was identified as a “Rising Star” by Super Lawyers for six years in a row and then a “Super Lawyer” for 6 years following that.
Rachel Abrams authored an article for Plaintiff Magazine, published January 2016, titled “The Pros and Cons of Multi-District Litigation Consolidation”.
Plaintiff Magazine featured Rachel with an in-depth two page profile in their December 2018 edition: “Rachel Abrams – Would-be marine biologist uses her scientific expertise to litigate against Big Pharma, medical device firms.
Uber Lyft JUUL Viagra & Cialis Pradaxa AndroGel Testosterone Therapy Talcum Powder Ovarian Cancer Zofran Birth Defects DePuy ASR Hip Implants Stryker Rejuvenate Hip Implants E-Cig Breast Implant DES Fen-Phen Sulzer-Hip Implants Medtronic-AneuRx Guidant-Ancure Zyprexa Seroquel Medtronic-Defibrillators Guidant-Defibrillators Avandia Gadolinium Based Contrast Agents Reglan
Contact Info:1700 Montgomery Street, Suite 250
San Francisco, CA 94111 Phone: (888) 426-4156 | (415) 426-3000 Email: email@example.com